Base to Base biotech podcast 26: Stand Up To Cancer Day
12 Sep 2025
Contributed by Lukas
This week, we have three interviews to mark Stand Up To Cancer Day. We have conversations with Simon...
Base to Base biotech podcast 25: Molecular glue degradation
05 Sep 2025
Contributed by Lukas
This week, we have an in-depth conversation on molecular glue degradation, with Monte Rosa Therapeut...
Base to Base biotech podcast 24: Dissecting the US cuts to mRNA vaccine projects and Herantis takes on Parkinson’s disease
29 Aug 2025
Contributed by Lukas
This week, we look at Herantis Pharma's work on Parkinson's disease, with the company's CEO, Antti V...
Base to Base biotech podcast 23: Digitalisation in labs, and are fibroblasts the future of regenerative medicine?
22 Aug 2025
Contributed by Lukas
This week, we have a wide-ranging conversation with Anna Codina, senior director strategy and busine...
Base to Base biotech podcast 22: A new treatment for dry AMD and tackling peanut allergies
15 Aug 2025
Contributed by Lukas
This week, we talk about new treatments for wet dry age-related macular degeneration (AMD) with Judi...
Base to Base biotech podcast 21: Elix drug discovery platform, and CytoAgents on CAR-T, CRS and the FDA
08 Aug 2025
Contributed by Lukas
This week, we talk about drug discovery with Shinya Yuki, co-founder and CEO of Elix Inc., and Teres...
Base to Base biotech podcast 20: Terumo BCT boosts CAR-T cell manufacturing, and Orbis on macrocycles
01 Aug 2025
Contributed by Lukas
This week, our conversations are with Wenyan Leong, director of APAC commercial and global strategic...
Base to Base biotech podcast 19: Nipro on dialysis and LenioBio on cell-free protein synthesis
25 Jul 2025
Contributed by Lukas
This week’s podcast is sponsored by Nipro.This week, our conversations are with Jesus Garcia, Nipr...
Base to Base biotech podcast 18: NETs and AI to tackle antimicrobial resistance
18 Jul 2025
Contributed by Lukas
This week, we have conversations with Eduardo Bravo, CEO of Citryll, and Dermot Tierney, COO of AMPL...
Base to Base biotech podcast 17: Silico nanoparticle gene delivery, and diagnosing urinary tract infections
11 Jul 2025
Contributed by Lukas
This week, our subjects are a silica nanoparticle gene delivery system in a conversation with Nigel ...
Base to Base biotech podcast 16: Domain Therapeutics, SandboxAQ and LinkGevity
04 Jul 2025
Contributed by Lukas
This week, we have conversations with Sean MacDonald, CEO of Domain Therapeutics, Carina Kern, CEO a...
Base to Base biotech podcast 15: Bio-convergence and cancer vaccines
27 Jun 2025
Contributed by Lukas
This week, we have conversations with Phil L'Huillier, CEO of Scancell, and Shai Melcer, head of Isr...
Base to Base biotech podcast 14: How to build reputation, and treating spastic paraplegia 47
20 Jun 2025
Contributed by Lukas
This week, we have conversations with Peter Nolan, CEO of BlackFinBio, and Kim Kraemer, CEO and foun...
Base to Base biotech podcast 13: Syngene commits to US market, and Nimbus Therapeutics on computational chemistry
13 Jun 2025
Contributed by Lukas
This week, we have conversations with Dr Peter Tummino, president of R&D at Nimbus, and Alex Del...
Base to Base biotech podcast 12: CLS boosts drug discovery capabilities, and Sitryx – pioneers in immunometabolism
06 Jun 2025
Contributed by Lukas
This week, our guests are Ben Cliff, CEO of UK-based CRO, Concept Life Sciences, and Ravi Rao, chief...
Base to Base biotech podcast 11: Turning cancer into a chronic disease, and a different way to draw blood
30 May 2025
Contributed by Lukas
This week, we have a conversation with Ben Zeskind, CEO and co-founder of Immuneering, and a discuss...
Base to Base biotech podcast 10: 3D printing human organs and early detection of ovarian cancer
23 May 2025
Contributed by Lukas
This week, we have a conversation with Vidmantas Šakalys, CEO of bioprinting company Vital3D Techno...
Base to Base biotech podcast 9: Microbiotica, 1Cell.Ai and Tessellate Bio at AACR
16 May 2025
Contributed by Lukas
This week, we’re talking to some of the companies that attended the American Association for Cance...
Base to Base biotech podcast 8: ‘Photoshop for proteins’ and improving operations
09 May 2025
Contributed by Lukas
This week on the podcast, we have a conversation with Elise de Reus, the co-founder of Cradle, a bio...
Base to Base biotech podcast 7: The DSCSA deadline and MoonLake's Nanobody
02 May 2025
Contributed by Lukas
This week on the podcast, we have a conversation with Tim Tinnel, executive vice president/chief ope...
Base to Base biotech podcast 6: Persica Pharmaceuticals and Caszyme
25 Apr 2025
Contributed by Lukas
This week on the podcast, we have a conversation with Steve Ruston, CEO of Persica Pharmaceuticals, ...
Base to Base biotech podcast 5: Vitalant’s vital role in blood products, and Brainomix gives hope to stroke victims
18 Apr 2025
Contributed by Lukas
This week on the podcast, we have a conversation with Vitalant’s Kevin Land, executive medical dir...
Base to Base biotech podcast 4: A new class of therapeutics, and biotech hiring in 2025
11 Apr 2025
Contributed by Lukas
This week on the podcast, we have conversations about hiring in the lifesciences industry in 2025, a...
Base to Base biotech podcast 3: Nanoparticles and Duchenne muscular dystrophy
04 Apr 2025
Contributed by Lukas
Interview timestamps: 02:20 Satellos 26:00 EVŌQ NanoAntibiotic-resistant infections are a top 10 gl...
Base to Base biotech podcast 2: Opioid alternatives and epiproteomics
28 Mar 2025
Contributed by Lukas
Our guest, Dr. Hernan Bazan, is the CEO and co-founder of South Rampart Pharma. He is also a board-c...
Base to Base biotech podcast 1: Osteoboost and Pheast Therapeutics
21 Mar 2025
Contributed by Lukas
Osteoboost Health Inc. just announced its sixth U.S. patent for its wearable device that uses vibrat...